Direxion Daily S&P Biotech Bear 3X ETF (LABD)

59.10 +4.26 (+7.77%) USD  |  NYSEARCA  |  May 24, 12:19

LABD Asset Allocations & Exposures

Asset Allocation

As of May 22, 2022.
Type % Net % Long % Short
Cash 119.3% Upgrade Upgrade
Stock -19.26% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Region Exposure

% Developed Markets: 0.00% % Emerging Markets: 0.00%
Americas 100.0%
North America
 Upgrade
United States Upgrade
Latin America
 Upgrade
As of May 22, 2022. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.00%
United Kingdom Upgrade
Europe Developed
 Upgrade
Europe Emerging
 Upgrade
Africa And Middle East
 Upgrade
Greater Asia 0.00%
Japan Upgrade
Australasia
 Upgrade
Asia Developed
 Upgrade
Asia Emerging
 Upgrade

Market Capitalization

As of May 22, 2022
Giant --
Large --
Mid --
Small --
Micro --

Stock Style Exposure

Large Cap Value --
Large Cap Blend --
Large Cap Growth --
Mid Cap Value --
Mid Cap Blend --
Mid Cap Growth --
Small Cap Value --
Small Cap Blend --
Small Cap Growth --
No Data Available
As of May 22, 2022

Stock Sector Exposure

Cyclical
0.00%
Basic Materials Upgrade
Consumer Cyclical Upgrade
Financial Services Upgrade
Real Estate Upgrade
Sensitive
0.00%
Communication Services Upgrade
Energy Upgrade
Industrials Upgrade
Technology Upgrade
Defensive
0.00%
Consumer Defensive Upgrade
Healthcare Upgrade
Utilities Upgrade
As of May 22, 2022